BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 19017822)

  • 1. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
    Schlessinger J; Miller B; Gilbert RD; Plott RT;
    Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
    Eichenfield LF; Basu S; Calvarese B; Trancik RJ
    Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
    Güven A; Gülümser O; Ozgen T
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
    Semiz S; Balci YI; Ergin S; Candemir M; Polat A
    Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler.
    Kennedy MJ; Carpenter JM; Lozano RA; Castile RG
    Ann Allergy Asthma Immunol; 2002 May; 88(5):523-6. PubMed ID: 12027076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
    Böckle BC; Jara D; Nindl W; Aberer W; Sepp NT
    Dermatology; 2014; 228(4):289-93. PubMed ID: 24751677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study.
    Grimalt R; Mengeaud V; Cambazard F;
    Dermatology; 2007; 214(1):61-7. PubMed ID: 17191050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical fluticasone propionate lotion does not cause HPA axis suppression.
    Hebert AA; Friedlander SF; Allen DB
    J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
    Ciccone S; Marini R; Bizzarri C; El Hachem M; Cappa M
    Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole.
    Bolland MJ; Bagg W; Thomas MG; Lucas JA; Ticehurst R; Black PN
    Ann Pharmacother; 2004 Jan; 38(1):46-9. PubMed ID: 14742792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.